Literature DB >> 21847524

Kinetics of effector functions and phenotype of virus-specific and γδ T lymphocytes in primary human cytomegalovirus infection during pregnancy.

Chiara Fornara1, Daniele Lilleri, M Grazia Revello, Milena Furione, Maurizio Zavattoni, Elisa Lenta, Giuseppe Gerna.   

Abstract

The T-cell response to human cytomegalovirus (HCMV) primary infection was analyzed in 27 pregnant women during the first year after primary HCMV infection. Pregnant women with remote HCMV infection were enrolled as controls. Interferon-γ-producing T cells were readily detected at levels comparable (CD4(+)) or higher (CD8(+)) than controls, whereas the CD4(+) and CD8(+) lymphoproliferative response as well as IL-2 production was significantly reduced with respect to controls for at least 9 months after infection. In addition, CD45RA re-expression as well as cytotoxic T lymphocyte activity and perforin expression were the major components of the adaptive CD4(+) and CD8(+) T-cell immune response, while Vδ2(-) γδ T-cell expansion in response to HCMV infection followed kinetics similar to that of CD8(+) T cells. Reduced CD45RA re-expression directly correlated with HCMV transmission to the fetus, thus providing an important prognostic parameter.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21847524     DOI: 10.1007/s10875-011-9577-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  41 in total

1.  Measuring T-cell-mediated cytotoxicity using antibody to activated caspase 3.

Authors:  Keith R Jerome; Derek D Sloan; Martine Aubert
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

2.  Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers.

Authors:  Maria Grazia Revello; Daniele Lilleri; Maurizio Zavattoni; Milena Furione; Emilia Genini; Giuditta Comolli; Giuseppe Gerna
Journal:  J Infect Dis       Date:  2005-12-09       Impact factor: 5.226

3.  Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients.

Authors:  Lionel Couzi; Vincent Pitard; Sonia Netzer; Isabelle Garrigue; Marie-Edith Lafon; Jean-François Moreau; Jean-Luc Taupin; Pierre Merville; Julie Déchanet-Merville
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

4.  Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells.

Authors:  Laura Lozza; Daniele Lilleri; Elena Percivalle; Chiara Fornara; Giuditta Comolli; Maria Grazia Revello; Giuseppe Gerna
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

5.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

6.  Passive immunization during pregnancy for congenital cytomegalovirus infection.

Authors:  Giovanni Nigro; Stuart P Adler; Renato La Torre; Al M Best
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

7.  Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus.

Authors:  Daniele Lilleri; Chiara Fornara; Milena Furione; Maurizio Zavattoni; Maria Grazia Revello; Giuseppe Gerna
Journal:  J Infect Dis       Date:  2007-02-20       Impact factor: 5.226

8.  Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells.

Authors:  George Makedonas; Natalie Hutnick; Danielle Haney; Alexandra C Amick; Jay Gardner; Gabriela Cosma; Adam R Hersperger; Douglas Dolfi; E John Wherry; Guido Ferrari; Michael R Betts
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

9.  Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

Review 10.  Measurement of CTL-induced cytotoxicity: the caspase 3 assay.

Authors:  K R Jerome; D D Sloan; M Aubert
Journal:  Apoptosis       Date:  2003-12       Impact factor: 4.677

View more
  23 in total

Review 1.  CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity.

Authors:  Tamara Tilburgs; Jack L Strominger
Journal:  Am J Reprod Immunol       Date:  2013-02-23       Impact factor: 3.886

2.  Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.

Authors:  Cody S Nelson; Ilona Baraniak; Daniele Lilleri; Matthew B Reeves; Paul D Griffiths; Sallie R Permar
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

Review 3.  Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.

Authors:  Bodo Plachter
Journal:  Med Microbiol Immunol       Date:  2016-08-12       Impact factor: 3.402

4.  Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.

Authors:  Raphaëlle Riou; Céline Bressollette-Bodin; David Boutoille; Katia Gagne; Audrey Rodallec; Maeva Lefebvre; François Raffi; David Senitzer; Berthe-Marie Imbert-Marcille; Christelle Retière
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

5.  Human cytomegalovirus (HCMV) long-term shedding and HCMV-specific immune response in pregnant women with primary HCMV infection.

Authors:  C Fornara; F Zavaglio; M Furione; A Sarasini; P d'Angelo; A Arossa; A Spinillo; D Lilleri; F Baldanti
Journal:  Med Microbiol Immunol       Date:  2022-08-12       Impact factor: 4.148

6.  The absence of p53 during Human Cytomegalovirus infection leads to decreased UL53 expression, disrupting UL50 localization to the inner nuclear membrane, and thereby inhibiting capsid nuclear egress.

Authors:  Man I Kuan; John M O'Dowd; Elizabeth A Fortunato
Journal:  Virology       Date:  2016-08-04       Impact factor: 3.616

Review 7.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

8.  Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection.

Authors:  Daniele Lilleri; Anna Kabanova; Maria Grazia Revello; Elena Percivalle; Antonella Sarasini; Emilia Genini; Federica Sallusto; Antonio Lanzavecchia; Davide Corti; Giuseppe Gerna
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

9.  Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.

Authors:  Daniele Lilleri; Giuseppe Gerna; Paola Zelini; Antonella Chiesa; Vanina Rognoni; Angela Mastronuzzi; Giovanna Giorgiani; Marco Zecca; Franco Locatelli
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

Review 10.  The pathogenesis of microcephaly resulting from congenital infections: why is my baby's head so small?

Authors:  L D Frenkel; F Gomez; F Sabahi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.